EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

计划入组 530 人 · 首次发布于 2021 年 12 月 9 日

ESCAPE Mechanistic Substudies - Ancillary to ESCAPE

首次发布于 2001 年 8 月 10 日

ESCAPE Migraine Trial

计划入组 168 人 · 首次发布于 2005 年 12 月 20 日

ESCAPE-1

Compound 34(ESCAPE Bio)

ESCAPE: Engineered Stem Cell Antibody Paired Evasion(Beam Therapeutics)

ESCAPE Bio, Inc.

United States

Beam Therapeutics

United States

MESO SCALE DIAGNOSTICS, LLC

United States

ESCAPE-MeVO Trial: Endovascular Thrombectomy Shows No Added Benefit for Medium Vessel Occlusion Stroke

Imperative Care Launches First Randomized Trial of Aspiration Thrombectomy for M2 Stroke Occlusions

New Trials Challenge Thrombectomy Benefits for Medium and Distal Vessel Stroke